肝细粒棘球蚴病合并结核性脓胸误诊为肝 肺细粒棘球蚴病1例

肝细粒棘球蚴病是由细粒棘球绦虫幼虫感染人或动物肝脏组织而引起的一种慢性寄生虫病。结核性脓胸是一种慢性活动性感染性疾病,主要侵犯胸膜间隙引起内脏、壁胸膜增厚。同时感染上述两种疾病的患者较为罕见。本文报道1例肝细粒棘球蚴病合并结核性脓胸误诊为肝、肺细粒棘球蚴病的病例,并结合相关文献进行分析讨论,旨在提高临床医师对该病的鉴别能力。     

3126例肝细粒棘球蚴病外科治疗

1974年 7月～ 2 0 0 3年 5月本院共收治肝细粒棘球蚴病 (又称肝包虫病 ) 3 12 6例 ,作者针对肝棘球蚴囊肿的结构类型 ,采取不同的手术方式 ,取得了较好的效果。报告如下。1　临床资料1.1　一般情况　本组 3 12 6例 ,男性 1865例 ,女性 12 61例 ,年龄 6～ 77岁 ,平均 41.5岁。1.2　结构类型　单发单子囊型 172 6例 (5 5 .2 1% ) ,单发多子囊型 480例 (15 .3 6% ) ,多发单子囊型 3 83例 (12 .2 5 % ) ,多发多子囊型 165例 (5 .2 8% ) ,多间隔多房多子囊型 3 72例 (11.90% )。1.3　部位　肝棘球蚴囊肿位于肝右叶 2 2 17例 (70 .92 % ) ,肝左叶 …     

云南省曲靖市细粒棘球蚴病一例

患者女性,31岁,云南省曲靖市沾益县德泽乡人。3年前B超检查肝左外叶囊性占位性病变,怀疑肝囊肿。2003年3月B超复查囊肿明显增大。2004年4月彩色B超查见肝左外叶约(8.4×7.6×6.9)cm的囊性无回声区,边界清楚,透声良好,诊断为肝囊肿。当天局部麻醉,行B超引导下肝囊肿穿刺,抽出的无色透明液体(277ml)中见许多淡黄色小颗粒状物。75%乙醇蛋白定性试验,2次均阴性。抽出液分别送本院检验科及昆明医学院寄生虫学教研室检查。送检液体无色透明,其中悬浮许多细粒棘球绦虫(Echinococcus granulosus)的原头蚴及囊壁碎片,确诊为肝细粒棘球蚴病，行肝棘球蚴病手术切除治疗。     

疑似精索细粒棘球蚴病2例

<正>2003-2008年甘肃省金昌市第一人民医院普外科收治疑似精索细粒棘球蚴病2例,现报告如下。1病例资料病例1,男,42岁,牧民,裕固族,甘肃省肃南县人。因腹     

人肝细粒棘球蚴病致病的研究进展

人肝细粒棘球蚴病是棘球蚴绦虫引起的一种人兽共患寄生虫病,也称肝包虫病,细粒棘球蚴的致病机制主要是对器官挤压,其次是细粒棘球蚴分泌的毒素对人体的毒性反应.目前,肝包虫病主要通过手术进行根治治疗.随着微创手术及精准手术标准的引用,腹腔镜手术治疗肝包虫病得到了长足的发展,本文将从腹腔镜肝包虫病适应症的选择、腹腔镜手术治疗肝包...     

肝泡状棘球蚴病

肝泡状棘球蚴病 (Ａｌｖｅｏｌａｒｅｃｈｉｎｏｃｏｃｃｏｓｉｓ ,Ａ ｅ .)是一种对人体危害极大的人畜共患的寄生虫病 ,由多房棘球绦虫的幼虫寄生于肝脏并不断增殖芽生 ,似癌样浸润扩散 ,造成肝组织不可逆的进行性损害。临床上具有慢性隐袭进行性的特点 ,常伴有肺及脑等重要器官转移。由于Ａ ｅ .具有一定的地区分布性 ,易于引起误诊 ,因此复习有关文献 ,提高Ａ ｅ .的全面认识 ,对临床诊治工作必将有所裨益。1　流行病学[1- 5]泡球蚴病主要流行于北半球高纬度地带。我国主要在西北地区流行。　　多房棘球绦虫的主要终宿主是狐及狼等野生…     

复杂性肝棘球蚴病外科治疗策略研究进展

肝棘球蚴病是一种由棘球属绦虫幼虫所致的人畜共患性疾病。我国主要致病绦虫类型为细粒棘球绦虫和多房棘球绦虫,分别引起细粒棘球蚴病和多房棘球蚴病。目前,棘球蚴病治疗已经取得重大进展,但对于部分就诊时已出现一种或多种并发症以及病灶侵及肝门、重要血管及胆管的复杂性棘球蚴病病例的治疗仍存在一定困难。本文根据近年来文献报道,结合临床经验,对复杂性肝棘球蚴病的外科治疗策略进行综述。［关键词］     

卵巢细粒棘球蚴病一例

卵巢包虫病较为少见。我们发现 1例无肝、肺和腹腔包虫囊肿的卵巢细粒棘球蚴病患者 ,报告如下。患者女性 ,4 7岁 ,回族 ,农民。生活于农牧区 ,与牛、羊、犬有密切接触史。下腹部发现包块半年 ,疼痛一月余。作者单位 :新疆尼勒克县人民医院 ,尼勒克 83570 0　　 2 0 0 1年 11月 7日来院就诊 ,以“腹腔包块 ,性质待查”入院。查体 :心、肺、肝、脾均未见明显异常。B超示下腹部混合性占位。 2 0 0 1年 11月 13日行剖腹探查术。术中见左侧卵巢囊性肿物 ,15 cm× 10 cm× 8cm,内见多个乳白色小囊泡 ,病理诊断 :卵巢细粒棘球蚴病。卵巢细粒棘球蚴…     

卵巢细粒棘球蚴病一例

患者 ,女 ,3 8岁 ,锡伯族 ,农民。与犬有过密切接触史。发现腹部包块 2年 ,伴月经紊乱、尿频。临床上以“卵巢囊肿”收住院。患者既往身体健康。体检 :一般情况良好 ,心肺未见异常。B超显示子宫多发性平滑肌瘤 ,左卵巢囊肿 ,肝胆未见异常。临床行“全子宫及左卵巢囊肿切除术” ,术中见左卵巢囊肿直径 6cm ,病理诊断为左卵巢细粒棘球蚴病 ,子宫多发性平滑肌瘤。细粒棘球蚴病在新疆多见 ,好发于肝、肺等脏器 ,发生于卵巢者较少见[1] 。本病在临床上主要表现为下腹部肿块 ,扪之呈囊性感 ,由于肿块刺激或压迫膀胱、尿道等附近组织器官 ,可出现…     

手术治疗邻近肝门部肝细粒棘球蚴病效果观察

目的 探讨手术治疗邻近肝门部的肝细粒棘球蚴病的效果。方法 回顾性分析2015年 11月至 2019年1月行外囊完整剥除术、外囊次全切除术及内囊摘除术的 20例共36个邻近肝门部的肝棘球蚴囊肿的手术疗效。结果 4个肝棘球蚴囊肿成功行外囊完整剥除术,30个肝棘球蚴囊肿成功行外囊次全切除术,2个肝棘球蚴囊肿因外囊与肝门血管粘连过于紧密且已经破裂入胆道而行内囊摘除术。肝门部大血管均保存完整,除1例因术前肝棘球蚴囊肿破裂入胆道(行内囊摘除术)而出现术后胆漏以外,余均无残腔并发症发生。结论 对于邻近肝门部的肝细粒棘球蚴病的手术治疗,外囊次全切除术与外囊完整剥除术较传统的内囊摘除术,术后胆漏、残腔感染等并发症发生率相对较低,可优先选择。但是还应根据囊肿的部位、大小及手术中具体情况选择具体的手术方式。     

Approaches to reconstruction of inferior vena cava by ex vivo liver resection and autotransplantation in 114 patients with hepatic alveolar echinococcosis

BACKGROUNDHepatic alveolar echinococcosis (AE) is most commonly found in retrohepatic inferior vena cava (RHIVC). Ex vivo liver resection and autotransplantation (ELRA) can better realize the radical resection of end-stage hepatic AE with severely compromised hepatocaval confluences, and reconstruction of the affected vessels. Currently, there is a scarcity of information regarding RHIVC reconstruction in ELRA.AIMTo propose reasonable RHICV reconstruction strategies for ex vivo liver resection and autotransplantation.METHODSWe retrospectively summarized the clinical data of 114 patients diagnosed with hepatic AE who treated by ELRA in our department. A total of 114 patients were divided into three groups according to the different reconstruction methods of RHIVC: Group A with original RHIVC being repaired and reconstructed (n = 64), group B with RHIVC being replaced (n = 43), and group C with RHIVC being resected without reconstruction (n = 7). The clinical data of patients, including the operation time, anhepatic phase, intraoperative blood loss, complications and postoperative hospital stay, were analyzed and the patients were routinely followed up. The normally distributed continuous variables were expressed as means ± SD, whereas the abnormally distributed ones were expressed as median and analyzed by analysis of variance. Survival curve was plotted by the Kaplan-Meier method.RESULTSAll patients were routinely followed up for a median duration of 52 (range, 12-125) mo. The 30 d mortality rate was 7.0% (8/114) and 7 patients died within 90 d. Among all subjects, the inferior vena cava (IVC)-related complication rates were 17.5% (11/63) in group A and 16.3% (7/43) in group B. IVC stenosis was found in 12 patients (10.5%), whereas thrombus was formed in 6 patients (5.3%). Twenty-two patients had grade III or higher complications, with the complication rates being 17.2%, 16.3%, and 57.1% in the three groups. The average postoperative hospital stay in the three groups was 32.3 ± 19.8, 26.7 ± 18.2, and 51.3 ± 29.4 d (P = 0.03), respectively.CONCLUSIONELRA can be considered a safe and feasible option for end-stage hepatic AE patients with RHIVC infiltration. The RHIVC reconstruction methods should be selected appropriately depending on the defect degree of AE lesions in IVC lumen. The RHIVC resection without any reconstruction method should be considered with caution.     

滤器植入结合溶栓/抗凝预防肺动脉栓塞的长期随访结果

目的分析应用静脉滤器结合栓和抗凝治疗在深静脉血栓患者治疗及预防肺动脉栓塞的长期随访结果.方法24例急性或亚急性深静脉血栓患者,其中男13例,女11例;年龄14～86岁,平均52.4岁.24例患者经皮经股静脉植入静脉滤器.2例在术中辅以深静脉导管尿激酶溶栓治疗,20例在术后进行尿激酶静脉溶栓治疗.同时皮下注射低分子肝素10 d.口服华法林6个月.结果全部病例介入操作成功.对全部病例临床平均随访15个月(10～48个月).术后一周内18例患者的下肢水肿及疼痛迅速消失,其余6例患侧肢体肿胀、无力症状均有不同程度减轻.本组没有发生滤器移位及腔静脉血栓阻塞和肺栓塞病例,也没有发生出血性并发症.结论静脉滤器植入结合溶栓和抗凝是治疗急性或亚急性下肢深静脉血栓形成的一种安全、有效的方法,并能有效地预防肺栓塞的发生.     

经下腔静脉途径拔除起搏导线的初步体会

目的 介绍应用血管内反推力技术经下腔静脉途径拔除起搏导线的初步临床体会。方法 对１８例患者的２８根导线应用血管内反推力牵引技术拔除导线,其中１６例（２５根导线）首选经上腔静脉途径,失败后改用经下腔静脉途径;２例（３根导线）直接用经下腔静脉途径拔除。结果 １６例患者的２５根导线,经上腔静脉途径完全拔除２２根（８８％）,３根经此途径拔除失败后改用下腔静脉途径,其中２根完全拔除。２例患者的３根导线直接先     

Temporary inferior vena cava filter for deep vein thrombosis and acute pulmonary thromboembolism: effectiveness and indication

Although the temporary inferior vena cava filter (IVC-F) is being used increasingly for protection against pulmonary thromboembolism (PTE), indications for its use are not established. Our strategy for the prevention of PTE is: (1) contraindication or failure of anticoagulation: permanent IVC-F; (2) for patients with residual proximal deep vein thrombosis (a) who have permanent risk factor: permanent IVC-F; (b) who have transient risk factor: temporary IVC-F; (3) others: no IVC-F. Temporary IVC-F was also implanted in deep vein thrombosis (DVT) patients without PTE who were preoperation or had floating thrombus. We investigated the outcome of patients given a temporary IVC-F versus those given a permanent IVC-F to clarify the efficacy and our strategy for implantation of a temporary IVC-F. Subjects were 12 men and 38 women with acute PTE and/or floating DVT admitted to our hospital between April 1999 and April 2002. Patient age was 25–91 years (mean 63 years). Eighteen patients were given a permanent IVC-F (group A) and 32 patients were given a temporary IVC-F (group B) as primary treatment, according to our criteria. There were no major complications in either group. Mortality after implantation of the IVC-F was 35% (6/17) in group A and 16% (4/25) in group B, with no significant difference (P = 0.14). Pulmonary thromboembolism recurred in 18% (3/17) of group A patients but in no group B patients (P = 0.10). All recurrences resulted in death. The 14 patients in group B who were not given a permanent IVC-F after removal of the temporary IVC-F survived. The temporary IVC-F can be used safely in patients with venous thromboembolism and is efficacious in preventing recurrence of PTE. Prognosis after removal of the temporary IVC-F is excellent.     

Budd-Chiari syndrome： A case with a combination of hepatic vein and superior vena cava occlusion

We here report a recent, rare case of Budd-Chiari syndrome, associated with a combination of hepatic vein and superior vena cava occlusion. A young female, who had been in good health, was admitted to our hospital because of massive ascites. The patient had used no oral contraceptives. Tests for coagulation disorders, hematological disorders, and antiphospholipid syndrome were all negative. Budd-Chiari syndrome was diagnosed by radiographic examination. The patient was suffering from a combination of hepatic vein and superior vena cava occlusion. In particular, the venous flow returned from the liver mainly through a right accessory hepatic vein, and stenosis was recognized at the orifice of this collateral vein into the vena cava. Subsequently, the patient underwent percutaneous balloon dilatation therapy for this stenosis. After this treatment, the massive ascites was gradually reduced, and she was discharged from our hospital. It has now been one year since discharge, and the patient has been doing well. If deteriorating liver function or intractable ascites occur again, a liver transplantation may be anticipated. This is the first case report of Budd-Chiari syndrome associated with a superior vena cava occlusion.     

Symptomatic inferior vena cava perforation by a retrievable filter: Report of two cases and a literature review

Inferior vena cava filters have been used frequently for decades to prevent pulmonary embolism in medical, surgical and trauma patients. With the advent of temporary or retrievable filters, the use of these filters has increased substantially. However, the enhanced design and attributes that make these devices attractive for short-term benefit and retrieval are not without risk. Two cases of symptomatic inferior vena cava wall penetration are reported - one of which required surgical intervention.     

肝包虫病与肝囊肿CT表现比较

目的 探讨使用256排CT检查在鉴别肝包虫病与肝囊肿方面的临床价值.方法 2017年4月 ～2020年11月我院诊治的肝囊肿患者77例和肝包虫病患者34例接受256排CT增强扫描检查,采用ELISA法检测血清抗囊液抗原抗体(EgCF)、抗头节抗原抗体(EgP)、抗囊液半纯化抗原抗体(EgB)和抗泡球蚴抗体(Em2).结...